Active Surveillance

What is Active Surveillance?

  • Involves close monitoring of small, slow-growing prostate cancer with relatively normal-looking cells (as determined by your biopsy results);
  • May be appropriate if you are an older man who may be more likely to develop other (age-related) conditions that may have a greater impact on your health;
  • Doesn’t involve invasive procedures
  • Doesn’t involve drugs
  • No side effects
Your prostate cancer will be monitored closely and may involve the following procedures:
 
  • Regular PSA tests and digital rectal exams
  • Monitoring PSA doubling time (this may mean having a PSA test done every 3-6 months)
    • PSA doubling time refers to how long it takes for a man’s level of prostate-specific antigen to double
  • Occasional repeat biopsies
  • Follow-up bone scan and/or CT scan to monitor disease progression
You will be offered more aggressive treatment at the first sign your prostate cancer has progressed or tumour has grown. Your doctor will discuss the advantages and disadvantages of each treatment option.  You should know that active surveillance is not a cure for prostate cancer.  It also carries the risk that your prostate cancer might spread (metastasize).  This is why regular monitoring is so important. 

You may have heard of the term “watchful waiting”.  Watchful waiting involves having no treatment for your prostate cancer.  Rather than treating the prostate cancer, your doctor will wait until you start having symptoms and treat those, usually with medication. The goal of watchful waiting is not to cure your prostate cancer, but treat your symptoms to make you feel better.
 
Related Links




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
4 Canadians deemed Rising Stars in Prostate Cancer Research

Toronto, ON - June 29, 2015: Prostate Cancer Canada (PCC) is proud to announce four awardees of Rising Stars in prostate cancer research grants.
More

14 innovative Canadian minds set out to make new discoveries in prostate cancer research grants awarded by Movember Foundation and Prostate Cancer Canada

Toronto, ON - June 25, 2015: Fourteen forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants, funded by the Movember Foundation through Prostate Cancer Canada (PCC).
More

Prostate Cancer Canada Raises Funds & Awareness for Canadian Men this Father’s Day

EDMONTON, ALBERTA – June 21st, 2015 – Friends, families and survivors from across the country joined Prostate Cancer Canada today to unite against prostate cancer.
More


Click here for news archive